CBA's BioEntrepreneur Event: The Changing Business Model for Biotech and Pharma: Outsourcing and Opportunities

6:30-8:30 PM, Fri, Sep 7, 2007, at Morgan, Lewis & Bockius LLP
2 Palo Alto Square, 3000 El Camino Real, Suite 607, Palo Alto, CA 94306

BioEntrepreneur Yahoogroup

Invited Speaker: Dr. Charles Hsu, Bay City Capital

Cost: $10 for non-member; Free for member and student with ID

Do you like to know the current business trend for biotech and pharma? Where are the opportunities in today's changing business model?

If your answer is yes, join us at our BioEntreprenur Club's event on September 7. Dr. Charles Hsu, a vertaran investor in life science, will share his view on what are the opportunities and good ideas/bad ideas on starting a bio-business. He will also talk about some successful/failed storied he has seen and his recent China's expereince.

Don't miss this great learning and netwroking opportunity.

Dr. Hsu has been an active venture capital investor since 1990. Prior to joining Bay City Capital, he was a venture partner of Pappas Ventures, and a General Partner of the Walden Group. He co-managed life sciences investments at Advent International, a global private equity firm based in Boston. He has served as a lead investor or board member for more than 25 life science and healthcare companies, and he was a founding investor of Ribozyme Pharmaceuticals. Some of his other realized investments include Aviron, KOSAN Biosciences, and Lexicon Genetics.

Dr. Hsu is a director and a co-founder of Asia Renal Care, the leading independent dialysis services company in Asia, and he is Chairman of Eureka! Pharmaceuticals. Dr. Hsu received his AB in Biochemistry from Harvard University, and his PhD and MBA from Stanford University. organized by the BioEntrepreneur Club of CBA